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Abstract
Background: In a subgroup of patients suffering from progressive multiple sclerosis (MS), which is an inflammation-
mediated neurodegenerative disease of the central nervous system (CNS), B cell aggregates were discovered within
the meninges. Occurrence of these structures was associated with a more severe disease course and cortical
histopathology. We have developed the B cell-dependent MP4-induced experimental autoimmune encephalomyelitis
(EAE) as a mouse model to mimic this trait of the human disease. The aim of this study was to determine a potential
role of lymphoid tissue inducer (LTi) and TH17 cells in the process of B cell aggregate formation in the MP4 model.
Methods: We performed flow cytometry of cerebellar and splenic tissue of MP4-immunized mice in the acute and
chronic stage of the disease to analyze the presence of CD3−CD5−CD4+RORγt+ LTi and CD3+CD5+CD4+RORγt+ TH17
cells. Myelin oligodendrocyte glycoprotein (MOG):35–55-induced EAE was used as B cell-independent control model.
We further determined the gene expression profile of B cell aggregates using laser capture microdissection, followed
by RNA sequencing.
Results: While we were able to detect LTi cells in the embryonic spleen and adult intestine, which served as positive
controls, there was no evidence for the existence of such a population in acute or chronic EAE in neither of the two
models. Yet, we detected CD3−CD5−CD4−RORγt+ innate lymphoid cells (ILCs) and TH17 cells in the CNS, the
latter especially in the chronic stage of MP4-induced EAE. Moreover, we observed a unique gene signature in CNS B
cell aggregates compared to draining lymph nodes of MP4-immunized mice and to cerebellum as well as draining
lymph nodes of mice with MOG:35–55-induced EAE.
Conclusion: The absence of LTi cells in the cerebellum suggests that other cells might take over the function as an
initiator of lymphoid tissue formation in the CNS. Overall, the development of ectopic lymphoid organs is a complex
process based on an interplay between several molecules and signals. Here, we propose some potential candidates,
which might be involved in the formation of B cell aggregates in the CNS of MP4-immunized mice.
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Background
To initiate adaptive immune responses and regulate im-
mune processes, highly complex structures, called
secondary lymphoid organs (SLOs), are formed during
embryogenesis. While SLOs are anatomically distinct
tissues and involved in acute inflammatory reactions, ec-
topic lymphoid structures can evolve when inflammation
persists for a long time [1]. The development of these
so-called tertiary lymphoid organs (TLOs) has been
mainly described to occur during the course of auto-
immune processes [2]. Beside in autoimmune diseases
like rheumatoid arthritis and myasthenia gravis [2], ec-
topic lymphoid structures have also been identified in a
subgroup of patients suffering from progressive multiple
sclerosis (MS) [3]. By analyzing postmortem brain tissue,
B cell follicle-like structures were discovered in the men-
inges of these patients [3]. Occurrence of such structures
was associated with a more severe disease course and
cortical histopathology [4]. These results suggest that
the presence of ectopic lymphoid tissue could play an
important role in the pathophysiology of MS. Indeed,
TLOs may provide suitable conditions for immune cells
to undergo maturation, to interact with each other, and
to subsequently trigger immune reactions, which aggra-
vate the disease course [5]. To further investigate the
role of TLOs in MS and to get deeper insights into the
formation of these structures we used experimental
autoimmune encephalomyelitis (EAE), which is the most
common mouse model of MS. We have previously
established MP4-induced EAE, which is induced by a fu-
sion protein consisting of the human isoform of myelin
basic protein (MBP) and the three hydrophilic domains
of proteolipid protein (PLP) [6]. Immunization with
MP4 triggers the activation of both antigen-specific T
cells and B cells, which can be detected in the blood,
along with MP4-specific IgG [6–9]. Similar to other EAE
models, MP4-immunized mice show immune cell infil-
tration into the central nervous system (CNS), including
both the brain and spinal cord [10]. Further studies have
shown a change in the composition of infiltrating cells
during the course of disease [11]. In contrast to the pres-
ence of CD4+ T cells, macrophages, and granulocytes in
the acute stage of the disease, chronic EAE mice
displayed a predominance of B cells, CD8+ T cells, and
dendritic cells. Moreover, we have demonstrated that B
cell-mediated processes take place in MP4-immunized
mice. On the one hand, B cell aggregates were observed
mainly in the cerebellum, which increasingly re-organized
into TLOs with compartmentalized B cell and T cell zones
and high endothelial venules (HEVs) [12]. In addition, we
have reported that CD10 is expressed by B cells within the
aggregates [13], which is thought to be a relevant marker
for B cell differentiation in follicular centers [14]. Further-
more, we have provided evidence of antibody isotype
switching in the CNS of MP4-immunized mice [13]. We
also detected different clonotypes in the cerebellum com-
pared to the spleen, and we observed antibody epitope
spreading [13]. Because of its B cell independence and the
absence of B cell aggregates, we also used myelin oligo-
dendrocyte glycoprotein (MOG):35–55-immunized mice
in the present study as a control model [11, 15]. Compar-
ing the structure and morphology of TLOs and SLOs, it
becomes obvious that ectopic lymphoid tissue resembles
SLOs in many aspects. In addition to a similar vascular
system, the cells and chemokines observed in TLOs are
comparable to those in SLOs [16]. During embryogenesis,
lymphoid tissue inducer cells (LTi) are considered as the
initiators of lymphoid organ formation [17, 18]. These
cells belong to the family of innate lymphoid cells (ILCs),
which are part of the innate immune system [19]. LTi cells
derive from the liver and migrate to induce the formation
of SLOs by lymphotoxin signaling, thereby stimulating
stroma cells [2, 20, 21]. The expression of chemokines and
adhesion molecules causes the recruitment of different
cells and finally the organization of the complex structures
[2, 21]. Whether LTi cells also contribute to the develop-
ment of ectopic lymphoid tissue in the brain of mice and
eventually of MS patients needs to be investigated. Previ-
ous research has demonstrated that LTi cells can induce
the formation of lymphoid tissue in the periphery of mice,
e.g., new Peyer’s patches [22, 23]. Recently, Serafini and
colleagues detected a small amount of CD3–RORγt+ cells,
potentially ILC3/LTi cells, in B cell aggregates/follicles
and adjacent diffuse meningeal infiltrates in secondary
progressive MS patients [24]. Another cell population,
which has also been associated with ectopic lymphoid tis-
sue formation, is TH17 cells. For instance, MOG:35–
55-specific TH17 were shown to induce the formation of
ectopic lymphoid tissue in the CNS of mice after passive
transfer into C57BL/6 (B6) recipient mice [25]. Appar-
ently, the induction relied on a close interaction between
TH17 cells, meningeal fibroblastic reticular cells, and the
secretion of CXCL13, which in turn was dependent on
lymphotoxin and necessary for B cell aggregation [26].
Interestingly, the comparison of the expression profile of
TH17 and LTi cells suggests striking similarity between
the two cell types. Markers like the transcription factor
RORγt in addition to CD4, interleukin (IL)-7R, IL-22, or
IL-17 have been reported in both cell populations
[19, 27]. One focus of our study was to investigate
the role of LTi and TH17 cells in ectopic lymphoid
tissue formation in the CNS of MP4-immunized mice.
Besides these two cell populations, it is conceivable
that several other factors are necessary to support the
highly complex structure of a TLO. To determine po-
tential other candidate molecules relevant to TLO
formation and maintenance, we also studied the gene
expression profile of B cell aggregates.
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Materials and methods
Mice
Six-week-old female B6 mice were purchased from
Janvier (France) and maintained at the animal facility of
the Zentrum für Mund- und Kiefergesundheit at the
University of Würzburg under specific pathogen-free
conditions. Mice were fed with a standard rodent diet
(Altromin Spezialfutter GmbH & Co. KG, Lage,
Germany) and autoclaved water. Food and water were
kept at ground level for mice displaying paralytic symp-
toms. Pregnant mice were obtained from the Institute of
Virology of the University of Würzburg to analyze the
embryonic stage of murine spleen development. A total
of 69 mice was used in our study. All animal experi-
ments were approved by the Regierung von Unterfran-
ken (approval number 91/14) and were in accordance
with the German Law on the Protection of Animals, the
“Principles of laboratory animal care” (NIH publication
no. 86–23, revised 1985) and the ARRIVE (Animal
Research: Reporting of In Vivo Experiments) guidelines.
EAE induction and clinical assessment
For immunization, incomplete Freund’s adjuvant (IFA)
was prepared by mixing paraffin oil (Sigma-Aldrich, St.
Louis, USA; Cat # 18512) and mannide monooleate
(Sigma-Aldrich; Cat # M8819) at a 9:1 ratio. Complete
Freund’s adjuvant (CFA) was subsequently obtained by
adding 5 mg/ml Mycobacterium tuberculosis H37 Ra
(Difco Laboratories, Franklin Lakes, NJ, USA; Cat #
231141) to IFA. After emulsifying MP4 (Alexion Phar-
maceuticals, Cheshire, CT, USA) in CFA, the mice were
immunized subcutaneously into both sides of the flank
with a total dose of 200 μg MP4. Additionally, an intra-
peritoneal injection of 200 ng pertussis toxin (List
Biological Laboratories, Hornby, ONT, Canada; Cat #
181) was given at the day of immunization and 48 h
later. For control purposes, mice were immunized with
MOG:35–55 (AnaSpec Inc., Fremont, CA, USA; Cat #
AS-60130-1) emulsified in CFA at a total dose of 100 μg
per mouse. Clinical assessment of EAE was performed
daily according to the standard EAE scoring system
(Table 1): (0) no disease, (1) floppy tail, (2) hind limb
weakness, (3) full hind limb paralysis, (4) quadriplegia,
and (5) death. Mice which were in between the defined
gradations of the scale were scored in increments of 0.25.
Our protocol required mice with a clinical disease score
greater than 3 to be culled. However, none of the animals
used for the experiments presented here fulfilled this cri-
terion. The disease course of both models is shown in
Fig. 1.
Tissue sampling and cell isolation for flow cytometry
analysis
Spleen and cerebellum
After culling the mice with CO2, the cerebellum and
spleen were dissected. Cells were isolated from the
spleen using 70-μm cell strainers. Cells were incubated
in lysis buffer for 10 min on ice to get rid of red blood
cells. Density gradient centrifugation was performed for
separating cells from the cerebellum. To this end, the
cerebellum was homogenized in 1× HBSS+/+ (Thermo
Fisher Scientific, Waltham, MA, USA; Cat # 14025-050).
Thereupon, the stock isotonic Percoll consisting of Per-
collTM Plus (GE Healthcare Bio-Sciences AB, Uppsala,
Sweden; Cat # 17-5445-02) and 10× HBSS−/− (Thermo
Fisher Scientific; Cat # 14185-045) was prepared. By
mixing the cell suspension with the stock a 30% solution
was obtained. To prepare a 70% solution, the stock
Table 1 Clinical disease parameters of EAE
EAE onset (days after immunization) Time point of experiment Final EAE score
Mice used for flow cytometry
MP4-immunized mice at acute stage of disease
n = 2 × 5 14.40 ± 0.37 16.00 ± 0.33 2.55 ± 0.20
MP4-immunized mice at chronic stage of disease
n = 1 × 5 and 1 × 6 18.18 ± 0.52 72.10 ± 0.31 2.48 ± 0.08
MOG:35–55-immunized mice at acute stage of disease
n = 2 × 5 11.90 ± 0.59 13.50 ± 0.50 2.58 ± 0.20
MOG:35–55-immunized mice at chronic stage of disease
n = 2 × 5 12.40 ± 0.79 54.00 ± 0.00 2.70 ± 0.06
Mice used for RNA sequencing
MP4-immunized mice at chronic stage of disease
n = 9 21.00 ± 1.59 58.44 ± 1.76 2.22 ± 0.22
MOG:35–55-immunized mice at acute stage of disease
n = 5 10.60 ± 0.40 13.00 ± 0.00 2.70 ± 0.05
The mean of the values ± SEM is shown
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isotonic Percoll was diluted with 1× HBSS−/− (Thermo
Fisher Scientific; Cat # 14185-045). The 30% solution
was slowly pipetted onto the 70% solution to set up a
density gradient and afterwards centrifuged at 500×g at
18 °C for 30 min without break. After the isolation of
cells from the interlayer, 1× HBSS+/+ (Thermo Fisher
Scientific) was used for washing and the cells were re-
suspended in phosphate-buffered saline (PBS). Cells of
both kinds of tissue were equally processed according to
the fluorescence-activated cell sorting (FACS) surface
and intracellular staining procedure.
Intestine
First, the extraction medium was prepared by mixing
RPMI medium (Thermo Fisher Scientific; Cat # 11875-
093), EDTA, and fetal bovine serum (FBS; GE Health-
care Life Sciences, South Logan, UT, USA; Cat #
SV30160.03). For the digestion solution, FBS was added
to RPMI medium. Mice were culled with CO2 and the
small intestine was dissected. Subsequently, the tissue
was kept in cold RPMI, containing 10% FBS. Fat was re-
moved from the small intestine, and a syringe with cold
PBS was used to get rid of the excrements. After cutting
the small intestine into segments and removing the re-
sidual fat, the intestinal segments were inverted from the
inside to the outside. Before using extraction medium,
dithiothreitol (DDT; Thermo Fisher Scientific; Cat #
R0861) was added to this solution. The tissue was stirred
in the extraction medium at 500 rpm and 37 °C for 15
min. Afterwards, the medium was strained to separate
tissue from the solution. The segments were washed in
RPMI and the residual mucus was removed by using a
dry paper towel. The digestion solution was mixed with
dispase (Thermo Fisher Scientific; Cat # 17105041) and
collagenase II (Worthington Biochemical Corporation,
Lakewood, NJ, USA; Cat # CLS-2) and the tissue was
homogenized in a small amount of this medium. Subse-
quently, this suspension and the residual digestion
medium were combined and stirred at 500 rpm and 37 °
C for 15 min. After pipetting the suspension up and
down, the stirring process was repeated. The digested in-
testine was filtered through a 70-μm strainer and before
centrifugation at 500×g at 4 °C for 10 min, RPMI con-
taining 10% FBS was added. The pellet was resuspended
and a further filtering step was performed by using a
40-μm cell strainer. The suspension was centrifuged
again at the same conditions. The pellet was resus-
pended in cold PBS and stained according to the proto-
col described below.
Embryonic spleen assay
Pregnant mice were culled at E 15 using CO2. After dis-
secting the uterus, embryos were removed from the
uterus horns. The embryos were kept on ice in PBS and
heads were cut off. The preparation of the spleen was
performed by using a microscope and forceps. The
following process was performed according to the previ-
ous protocol for the isolation of adult spleen cells.
Staining of surface markers
Cell suspensions were incubated with BD Horizon™ Fix-
able Viability Stain 450 (BD Biosciences, San Jose, CA,
USA; Cat # 562247) at 4 °C for 30 min in the dark except
the intestinal tissue and washed with ice-cold PBS. For
the intestine, Fixable Viability Stain 520 (BD Biosciences;
Cat # 564407) was used at 4 °C for 15 min in the dark.
After adding anti-mouse CD16/CD32 (Thermo Fisher
Scientific; Cat # 14-0161-85) to the samples, they were
kept for 20 min in the fridge followed by a washing step.
Subsequently, cells were stained with fluorochrome-con-
jugated anti-mouse antibodies at 4 °C for 30 min in the
dark. Afterwards, FACS FlowTM (BD Biosciences; Cat #
342003) was added for washing.
Intracellular staining
Foxp3 fixation/permeabilization working solution was
prepared consisting of one part of Foxp3 fixation/
permeabilization concentrate (Thermo Fisher Scientific;
Fig. 1 Clinical disease course of a MP4 (n = 20)- and b MOG:35–55 (n = 10)-induced EAE, shown until day 54 after immunization. The EAE score
was assessed daily. Mean values ± SEM are given
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Cat # 00-5123-43) and three parts of fixation/
permeabilization diluent (Thermo Fisher Scientific; Cat
# 00-5223-56). Additionally, 10× permeabilization buffer
(Thermo Fisher Scientific; Cat # 00-8333-56) was diluted
with distilled water to obtain a 1× buffer. After adding
the working solution to the cells, they were incubated at
room temperature in the dark for 45 min and washed by
using the 1× permeabilization buffer. Subsequently,
mouse serum (Sigma-Aldrich; Cat # M5905) was pipet-
ted onto the samples. After an incubation time of 15
min at room temperature, fluorochrome-labeled anti-
bodies were added to the cells, which were then kept
protected from light at room temperature for 30 min.
Finally, the cells were washed with 1× permeabilization
buffer and FACSFlowTM (BD Biosciences). For flow
cytometry analysis the samples were resuspended in
FACSFlowTM (BD Biosciences).
Flow cytometry analysis
Cerebellum, adult and embryonic spleen, intestine
All samples were measured on a FACS CantoTM II flow
cytometer (BD Biosciences). The following fluorochrome
-conjugated anti-mouse antibodies were selected for
identification of ILCs, LTi, and TH17 cells: anti-CD4,
anti-CD3ε, and anti-CD5 for surface staining and
anti-RORγt for intracellular staining (Table 2). To
characterize LTi cells in the small intestine, we addition-
ally used anti-mouse CD127 antibody. The analysis of
the data was performed with FlowJo software (version
10.07 for Windows, Tree Star, Ashland, OR, USA). The
following gating strategy was applied to separate ILC,
LTi, and TH17 cells (Fig. 2). Undesirable cell populations
and doublets were eliminated by using cell size (forward
scatter (FSC)) and the granularity (sideward scatter
(SSC)). After exclusion of dead cells, surface markers
and the intracellular marker were used to characterize
the cells. To differentiate between LTis and TH17 cells,
cells were divided into CD3−CD5− cells and CD3+CD5+
cells. Former studies have described a T cell contamin-
ation in the ILC gate when only using CD3 to separate T
cells from ILCs. Accordingly, the additional use of CD5
was suggested to exclude undesirable T cells [28].
Subsequently, two-parameter density plots, with CD4 on
the x-axis and RORγt on the y-axis, were used to
finally identify CD3−CD5−CD4+RORγt+ LTi cells and
CD3+CD5+CD4+RORγt+ TH17 cells. Additionally,
CD3−CD5−CD4−RORγt+ ILCs were determined by
following the first steps of the LTi gating strategy.
To distinguish between LTi cells and other members
of the third group of ILCs, we have included CD4 as
an additional marker [19].
Tissue sampling and cryosectioning
The following procedures for gene sequencing analysis
were performed under RNAse-free conditions. Mice
were culled with CO2. After the dissection of the cere-
bellum and lymph nodes, the tissue was embedded in
Tissue-Tek® (Sakura, Torrance, CA, USA; Cat # 4583)
and frozen in liquid nitrogen. Until the continuation of
the experiments, samples were preserved at − 80 °C. The
frozen tissue was cut into 10-μm-thick sections using a
Leica CM3050 S cryostat. For laser capture microdissec-
tion (LCM), samples were placed on FrameSlides (Leica;
MicroDissect GmbH, Herborn, Germany; Cat #
11505190), which are special microscope slides, consist-
ing of a polyethylene terephthalate (PET) membrane and
a steel frame. Furthermore, SuperFrost® Plus slides
(Thermo Fisher Scientific; Cat # J1810AMNT) were
used for every fifth section to perform immunohisto-
chemical analysis. All slides were stored at − 80 °C until
further analysis.
Immunohistochemical analysis
Cryosections were dried at room temperature for 2 h.
During the following entire procedure, washing steps
were performed in between. The sections were fixed
with 4% paraformaldehyde (PFA) at room temperature
for 10 min, protected from light. To inhibit endogenous
peroxidase activity, the tissue was exposed to aqueous
3% hydrogen peroxide (H2O2) solution for 10 min at
room temperature in the dark. Afterwards, 5% normal
goat serum (NGS; Sigma-Aldrich; Cat # G9023) in PBS
was pipetted onto every slide for 1 h incubation to block
unspecific binding. Subsequently, samples apart from
control slides were incubated overnight at 4 °C protected
from light with primary rat anti-mouse B220 antibody
(Thermo Fisher Scientific; Cat # 14-0452-81; 1:1000
dilution). The next day, goat anti-rat IgG antibody
(Vector Laboratories; Maraval LifeSciences, Burlingame,
CA, USA; Cat # BA-9400; 1:500 dilution) was added.
Table 2 Antibodies used for flow cytometry
Antibody Host species Fluorochrome Clone Catalog no. Origin
Anti-mouse CD3ε Hamster Brilliant Violet 510TM 145-2C11 100353 BioLegend, San Diego, CA, USA
Anti-mouse CD4 Rat PerCP-Cy™ 5.5 RM4-5 561115 BD Biosciences, San Jose, CA, USA
Anti-mouse CD5 Rat Brilliant Violet 510TM 53-7.3 100627 BioLegend, San Diego, CA, USA
Anti-mouse CD127 Rat BV421 SB/199 562959 BD Biosciences, San Jose, CA, USA
Anti-mouse RORγt Rat APC B2D 17-6981-82 Thermo Fisher Scientific, Waltham, MA, USA
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After an incubation time of 1 h in the dark at room
temperature, samples were exposed to avidin-biotin
complex (Vectastain® ABC Kit, Peroxidase Standard,
Vector Laboratories; Cat # PK-4000) at room
temperature in the dark for 30 min. To start the staining
reaction, DAB Peroxidase Substrate Kit (Vector Labora-
tories; Cat # SK-4100) was pipetted on the tissue and the
process was monitored by using a Zeiss Primo Star light
microscope until a dark brown reaction product was
visible. For stopping the staining process, PBS was used.
Before dehydrating samples in ethanol and xylene baths,
the tissue was stained with 0.1% Kernechtrot (Merck,
Darmstadt, Germany; Cat # 5189) dissolved in 5%
aluminiumsulfate-18-hydrate (Sigma-Aldrich; Cat #
11044) solution. Finally, the samples were mounted in
DePeX (Serva, Heidelberg, Germany; Cat # 18243.02). For
additional T cell staining, rabbit anti-mouse CD3 antibody
(abcam, Cambridge, UK; Cat # ab21703) was used in
Fig. 2 Flow cytometry gating strategy for identification of ILCs, LTi, and TH17 cells in EAE mice. Forward scatter area (FSC-A) and height (FSC-H)
were used to exclude cells, which had formed doublets. The lymphocyte gate was determined by using FSC-A and sideward scatter area (SSC-A).
Viable cells were separated from dead cells. Cells were divided into CD3−CD5− and CD3+CD5+ cells. CD3−CD5− cells were further analyzed for the
presence of LTi cells and ILCs, and CD3+CD5+ cells were further analyzed for TH17 cells. CD3
−CD5− cells being positive for CD4 and RORγt
represented CD3−CD5−CD4+RORγt+ LTi cells. Moreover, CD3−CD5−CD4−RORγt+ cells appeared in the ILC gate. CD3+CD5+ cells, which were also
positive for CD4 and RORγt, occurred in the gate of TH17 cells
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combination with Vector Blue development (Vector Blue
Alkaline Phosphatase Substrate Kit, Vector Laboratories;
Cat # SK-5300). Immunohistochemical staining was per-
formed prior to laser capture microdissection to identify B
cell aggregates in MP4-immunized mice and typical T cell
infiltrates in the MOG:35–55 model.
LCM and RNA isolation
Before starting the analysis, a 1% cresyl violet acetate
solution was prepared by dissolving cresyl violet acetate
(Sigma-Aldrich; Cat # C5042) in 50% ethanol. Subse-
quently, the prepared FrameSlides (Leica) were placed in
70% ethanol for 2min. After staining the samples for 30 s
with 1% cresyl violet acetate solution, the slides were
shortly dipped in 70% ethanol followed by 100% ethanol.
The slides were dried at room temperature for 2min prior
to using the microscope. To perform LCM, the LCM
microscope and laser system (Leica LMD700) of the De-
partment of Food Chemistry of the University of Würzburg
was used. The target structures were cut out of the stained
tissue by the laser. The dissected tissue was captured in
RNase-free tubes and kept on dry ice. For isolation of
RNA, RNeasy® Micro Kit (Qiagen, Hilden, Germany; Cat #
74004) was used according to the manufacturer’s
instructions. RNA samples were stored at − 80 °C.
Gene sequencing
The following procedure was performed by the Core
Unit Systems Medicine (CU SysMed) at the Medical
Faculty of the University of Würzburg. Bioanalyzer 2100
(Agilent Technologies, Santa Clara, CA, USA) was used
to test RNA quantity and quality. Libraries for RNA se-
quencing were prepared from 8–28 ng of total RNA.
After purification of poly-A RNA from each sample, it
was converted to cDNA and linked to Illumina adapters
by using the Illumina TruSeq stranded mRNA Kit
following the manufacturer’s instructions (Illumina, San
Diego, CA, USA). Subsequently, samples were multi-
plexed and the sequencing was performed on an Illu-
mina NextSeq 500 in a 75-nt single-end setting using a
high-output run mode. The generated raw reads were
processed using FastQC 0.11.6 for assessing read quality,
amount of duplicates, and presence of adapter
sequences. After this, the Illumina TruSeq adaptors were
cleaved using cutadapt (version 1.16) and resulting reads
were further trimmed keeping a quality drop value
below a mean of Q20. Further, the processed sequences
were mapped to the mouse genome using the short read
aligner STAR (version-2.5.2b) with genome and annota-
tion files retrieved from GENCODE (July 2017,
GRCm38.p5, M16). For all the studied samples, the pro-
portion of reads mapped to the mouse reference genome
ranged between 81% and 83% in total. The sequences
aligning to specific genes were quantified using bedtools
subcommand intersect (version 2.15.0). Next, the differ-
entially expressed genes were identified using DESeq2
(version 1.16.1). Only the genes having a Benjamini-
Hochberg corrected p value below 0.05 were classified
as significantly differentially expressed (DEGs). The data
were visualized as MA plot using DESeq2’s function
plotMA. To compare the groups, heatmaps were used to
represent genes having p adjusted values below 0.05 and
an absolute log2 fold-change equal or above 2. The RNA
sequencing data presented in this work have been depos-
ited at the NCBI Gene Expression Omnibus and can be
accessed through GEO series accession number GSE
GSE125144 (https://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE125144).
Statistical analysis
Statistical analysis was used to determine the signifi-
cance between the different amounts of TH17 cells in
the different groups of mice. Statistical analysis and pre-
processing of the data were performed using SciPy
(1.1.0), StatsModels (0.9.0), scikit-learn (0.19.1), and the
imbalanced-learn package (0.3) with Python 3.6.6. The
data of the different groups were first upsampled to
obtain at least four samples via the “resample” method
from scikit-learn, which is the first step of the bootstrap-
ping method. From this point on, the data of the corre-
sponding groups were upsampled via the synthetic
minority oversampling technique (SMOTE class from
the imbalanced-learn package). Interpolated newly
generated samples were obtained until the number of
samples was matched from which the pooling of the
data originated (10 for all groups except 11 for the mice
with chronic EAE). The Shapiro-Wilk test revealed that
the data were not drawn from a normal distribution.
The consecutively performed Kruskal-Wallis H test for
independent samples as a non-parametric test was then
applied followed by the computation of the Tukey Hon-
est Significant Differences (TukeyHSD). p values < 0.05
were considered as significant.
Results
LTi cells are absent in the cerebellum of EAE mice
For flow cytometry experiments of the cerebellum and
spleen, ten mice in each group (11 for the chronic stage
of MP4-induced EAE) were divided into two cohorts
and the tissues for each cohort were pooled.
MP4-immunized B6 mice were analyzed either at the
peak of disease (n = 2 × 5) or at the chronic stage of
disease (n = 1 × 5 and 1 × 6) by flow cytometry. For ana-
lyzing mice during acute EAE, the animals were culled
16.00 ± 0.33 days after immunization with a mean score
of 2.55 ± 0.20. To study the chronic stage of EAE, we
analyzed mice with a mean score of 2.48 ± 0.08 at 72.10
± 0.31 days after immunization. Furthermore, the same
Schropp et al. Journal of Neuroinflammation          (2019) 16:111 Page 7 of 15
experiments were performed for MOG:35–55-immu-
nized B6 mice during acute (n = 2 × 5) and chronic EAE
(n = 2 × 5). These mice were culled 13.50 ± 0.50 days
after immunization showing a mean score of 2.58 ± 0.20
and after 54 days with a mean score of 2.70 ± 0.06.
Non-immunized mice (n = 2 × 5) served as controls. For
analyzing the infiltrating immune cells within the CNS,
we focused on the cerebellum, because in previous stud-
ies, we could confirm the presence of infiltrates in the
cerebellum of both mouse models and the preferential
formation of B cell aggregates in MP4-induced EAE in
this brain region [10, 11]. As shown in Fig. 3 and Table 3,
no significant amount of CD3−CD5−CD4+RORγt+ LTi
cells could be detected in the cerebella of control and
EAE mice. In addition, LTi cells were absent in the
spleens of all three groups (Table 4). To confirm the
functionality of our staining process and gating strategy,
we measured intestinal cells of adult mice and spleen
Fig. 3 Flow cytometry data for LTi cell identification. The experiments were performed in non-immunized control and different groups of EAE
mice. Cells were gated to detect CD3−CD5−CD4+RORγt+ LTi cells in the cerebellum. a Non-immunized mice were compared to b MP4-
immunized EAE mice in the acute and chronic stage of disease and to c MOG:35–55-immunized EAE mice in the acute and chronic stage
of disease
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cells of embryos (Fig. 4). We detected a small amount of
0.24% ± 0.06 LTi cells in the intestine of n = 2 mice. To
perform analysis of embryonic tissue, 16 embryonic
spleens were pooled of two pregnant mice. While the
spleens of the adult mice showed no presence of LTi
cells, embryonic tissue possessed a slightly increased
number of 0.98% of the desired cell population.
ILCs are present in the cerebellum of EAE mice
We also determined whether ILCs were present in the
cerebellum of EAE mice. We used the same groups of
mice as for LTi cell analysis and followed the gating
strategy shown in Fig. 2. ILCs were characterized as
CD3−CD5−CD4−RORγt+. In contrast to LTi cells, we
detected a small number of ILCs, especially in the acute
stage of the disease in the MP4 model and at both time
points in MOG:35–55-immunized mice (Fig. 5, Table 3).
TH17 cells infiltrate the cerebellum of EAE mice
For TH17 identification, we analyzed the same mice as
above but used another gating strategy (Fig. 2). Figure 6
and Table 3 demonstrate that CD3+CD5+CD4+RORγt+
TH17 cells were present in the cerebellum of all EAE
mice. Moreover, we observed an increase of this cell
population during the course of MP4-induced EAE.
Compared to 1.82% ± 0.10 TH17 cells detected at the
peak of disease, the chronic cohorts of MP4-immunized
B6 mice showed a significant increase to 5.66% ± 0.22
TH17 cells (p < 0.05). Only a slight increase was observed
in MOG:35–55-induced EAE. Here, we detected 2.82 ±
0.18% of TH17 cells in the acute stage of the disease and
3.16 ± 0.02% of TH17 cells in the chronic stage. In
non-immunized B6 mice, TH17 cell infiltration into the
cerebellum was not observed. Compared to the cerebel-
lum, only a small number of TH17 cells could be
detected in the spleens of MP4- and MOG:35–55-im-
munized mice (Table 4).
Characterization of gene expression in B cell aggregates
of MP4-immunized mice
MP4-immunized mice were dissected 58.44 ± 1.76 days
after immunization showing a mean score of 2.22 ± 0.22.
Mice suffering from MOG:35–55-induced EAE were
culled 13 days after immunization with a mean score of
2.70 ± 0.05. While B cell aggregates are generally not ob-
served in the MOG:35–55 model [11], MP4-immunized
mice were kept until the chronic stage of the disease to
ensure that B cell aggregates had developed, which were
defined as tight perivascular clusters of more than 20 B
cells. Using LCM, immune cell infiltrates were isolated
from each respective tissue. Gene expression profiles of
B cell aggregates that had been isolated from the cere-
bellum of mice with MP4-induced EAE were compared
to immune cell infiltrates of MOG:35–55-immunized
mice, which mainly consisted of T cells, and to B cell fol-
licles from the draining lymph nodes derived from both
models. Genes showing a log2 fold-increase equal or
above 2 and a p value below 0.05 in B cell aggregates
compared to the other samples were selected and sum-
marized using a heatmap (Fig. 7). Our results show a
significant upregulation of genes of different families in
B cell aggregates of MP4-immunized mice compared to
the controls. Besides Il17f, we detected two members of
the matrix metalloproteinase (Mmp) gene family, i.e.,
Mmp3 and Mmp10; heat shock protein (Hsp) genes of
the Hsp70 family, i.e. Hspa1a, Hspa1b, and heat shock
protein 1-like (Hspa1l); and family with sequence simi-
larity 19, member A2 (Fam19a2). Moreover, the
Table 4 Percentage of LTi and TH17 cell in the spleens of MP4-
immunized and control mice
Mouse model % of LTi cells % of TH17 cells
Non-immunized B6 mice
n = 2 × 5 0.012 ± 0.005 0.155 ± 0.005
MP4-immunized mice at acute
stage of disease
n = 2 × 5 0.013 ± 0.007 0.550 ± 0.100
MP4-immunized mice at chronic
stage of disease
n = 1 × 5 and 1 × 6 0.009 ± 0.002 0.435 ± 0.045
MOG:35–55-immunized mice
at acute stage of disease
n = 2 × 5 0.003 ± 0.003 0.565 ± 0.105
MOG:35–55-immunized mice
at chronic stage of disease
n = 2 × 5 0.019 ± 0.000 0.375 ± 0.005
The values relate to the percentage of living lymphocytes. The mean of the
values ± SEM is shown
Table 3 Percentage of LTi, TH17 cells, and ILCs in the
cerebellum of MP4-immunized and control mice
Mouse model % of LTi cells % of TH17 cells % of ILCs
Non-immunized B6 mice
n = 2 × 5 0.000 ± 0.000 0.00 ± 0.00 0.22 ± 0.01
MP4-immunized mice at
acute stage of disease
n = 2 × 5 0.018 ± 0.018 1.82 ± 0.10 0.67 ± 0.25
MP4-immunized mice at
chronic stage of disease
n = 1 × 5 and 1 × 6 0.027 ± 0.006 5.66 ± 0.22 0.24 ± 0.02
MOG:35–55-immunized mice
at acute stage of disease
n = 2 × 5 0.000 ± 0.000 2.82 ± 0.18 0.87 ± 0.35
MOG:35–55-immunized mice
at chronic stage of disease
n = 2 × 5 0.004 ± 0.001 3.16 ± 0.02 0.67 ± 0.12
The values relate to the percentage of living lymphocytes. The mean of the
values ± SEM is shown
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complement component factor i (Cfi) and the chloride
channel accessory 3A2 (Clca3a2) gene were upregulated.
Further genes were glutamate rich 3 (Erich3), IQ motif
and Sec7 domain 3 (Iqsec3), guanine nucleotide binding
protein, alpha 14 (Gna14), protein phosphatase with EF
hand calcium-binding domain 1 (Ppef1), and secreted
frizzled-related protein 1 (Sfrp1).
Discussion
The aim of our study was to investigate key mechanisms
and molecules involved in the formation of B cell aggre-
gates in the CNS of MP4-immunized mice. A particular
focus was set on the role of LTi cells. Some studies have
already provided evidence for the involvement of LTis in
the formation of TLOs. Meier and colleagues have
shown that an overexpression of interleukin-7 (IL-7) in
transgenic mice induced the accumulation of LTi cells
and the development of new Peyer’s patches, ectopic
lymph nodes, and cecal patches [22]. Further experi-
ments have demonstrated the formation of intestinal
lymphoid tissue after transfer of LTi cells into CXCR5−/−
newborn mice [23]. Besides LTi cells, TH17 cells also
seem to play an important role in TLO development.
The transfer of MOG-specific TH17 cells led to the for-
mation of ectopic lymphoid tissue in the CNS of mice.
IL-17 and the TH17 cell surface molecule podoplanin
have initially been suggested to be involved in this
process [25], while further investigation has demon-
strated that podoplanin also has an inhibitory effect on
T cells [29]. Hence, podoplanin might play a dual role in
TLO development, which needs to be further investi-
gated. Here, we set out to identify the roles of LTi cells
in the CNS of mice suffering from EAE, in particular in
the MP4 model, which is characterized by ectopic
lymphoid tissue formation in the chronic stage of the
disease [12]. B cell aggregates were also described in pa-
tients suffering from secondary progressive MS and were
associated with more rapid disease progression and cor-
tical histopathology [3, 4]. Although MP4-immunized
mice do not display disease progression so that B cell
aggregate formation cannot be correlated to clinical
disease parameters, MP4-induced EAE represents a
Fig. 4 Flow cytometry data for LTi cell identification in mouse embryonic spleen and adult intestinal tissue. Comparison between a embryonic
and adult spleen cells. CD3−CD5−CD4+RORγt+ LTi cells of splenic tissue are shown in the gates. b Flow cytometry analysis of intestinal tissue.
CD3−CD5−CD4+RORγt+ LTi cells are shown in the gate
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convenient model to study key molecules and mecha-
nisms involved in the development of ectopic lymphoid
organs [12]. Our data demonstrate the absence of LTi
cells in the cerebella of MP4- and MOG:35–55-immu-
nized mice throughout the disease course. While LTi
cells have been shown to induce the development of ec-
topic lymphoid tissue in the periphery of mice [22, 23],
our results provide no evidence of a key role of this cell
population in the CNS of EAE mice. As positive control,
we analyzed the presence of LTi cells in the embryonic
spleen. LTi cells migrate from the liver to the target
tissue, where they induce the development of SLOs [21].
Therefore, LTi cells can be detected in the spleen during
embryogenesis [30]. For adult mice, we used the intes-
tine as a positive control. Studies have shown that LTi
cells persisted in the intestine and were important to
support the innate immune system [31, 32]. Along these
lines, we detected a low number of LTi cells both in the
embryonic spleen and in the intestine of adult mice. In
humans, the occurrence of CD3−RORγt+ ILCs has been
described in the CNS of a subgroup of MS patients in
association with B cell follicle-like structures [24].
Fig. 5 Flow cytometry data for CD4- ILC identification. The same mouse groups as for LTi cell identification were used. The gates represent
CD3−CD5−CD4−RORγt+ ILCs in the cerebellum. The figure shows the comparison between a non-immunized, b MP4-immunized mice in the
acute and chronic stage of the disease and c MOG:35–55-immunized mice in the acute and chronic stage of the disease
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According to our definition of LTi cells, being described
as CD3-CD5−CD4+RORγt+, the results of Serafini and
colleagues are not in conflict with our data because of
no further characterization of CD3−RORγt+ cells in their
paper [24]. Nevertheless, we cannot exclude that few LTi
cells still migrate into the CNS of MP4-immunized mice
or are present at an earlier time point to induce lymph-
oid tissue formation. Detection of small cell populations
always implicates difficulties. LTi cells represented a
minority of the total leukocyte population in our control
tissues and, therefore, it might be hard to detect a
possibly even smaller amount in the cerebellum. Similar
to the paper of Serafini, we also detected CD3−RORγt+
cells in the cerebellum of EAE mice, which we defined
as CD3−CD5−CD4−RORγt+ ILCs. Overall, the numbers
detected in our study were quite low. Only a slight in-
crease could be observed during the acute stage of
MP4-induced EAE and in the MOG:35–55 model. While
B cell aggregates are a hallmark of the chronic stage of
MP4-induced EAE, these structures do not occur in
MOG:35–55-immunized mice [11]. In particular,
chronic MP4-immunized mice showed almost no ILCs.
Fig. 6 Flow cytometry data for TH17 cell identification. The same groups of mice were analyzed as for LTi cell identification. The gates show
CD3+CD5+CD4+RORγt+ TH17 cells in the cerebellum. The comparison between a non-immunized, b MP4-immunized mice during acute and
chronic EAE and c MOG:35–55-immunized mice during acute and chronic EAE is shown
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Moreover, the amount of ILCs, which were detected in
the acute stage of MP4-induced EAE, was comparable to
the numbers of MOG:35–55-immunized mice. There-
fore, it remains unclear if ILCs play any important role
in ectopic lymphoid tissue formation in the CNS. Next
to LTi cells and ILCs, we focused on the presence of
CD3+CD5+CD4+RORγt+ TH17 cells in the cerebellum of
EAE mice. According to the human study, which
showed a much higher frequency of CD3+RORγt+ than
of CD3−RORγt+ cells [24], we also detected
CD3+CD5+CD4+RORγt+ TH17 cells in the CNS of both
mouse models. Sharing a lot of common markers with
LTi cells [27], it becomes obvious that TH17 cells could
possibly undertake the tasks of LTi cells in the process
of lymphoid tissue formation. Yet, they may not be the
only decisive factor. On the one hand, one would expect
the highest number of TH17 cells in the acute MP4 cere-
bellum. On the other hand, although the MOG:35–55
model is characterized by lack of B cell aggregates in the
CNS [11], the frequencies of TH17 cells were compar-
able between the MP4 and MOG:35–55 model during
the acute stage of the disease. Only a slight increase in
the number of TH17 cells was observed in chronic
MP4-immunized mice, which may also be attributed to
the gating strategy. Overall, the formation of B cell
aggregates and their evolution into ectopic lymphoid
structures is certainly a complex process that involves
more than one cell type and molecule. Indeed, when
Fig. 7 RNA sequencing analysis of B cell aggregates. a Dissected tissue comprised B cell aggregates from the cerebellum of MP4-immunized
mice, diffuse immune cell infiltrates from the cerebellum of MOG:35–55-immunized mice and isolated B cell follicles from the draining lymph
nodes of both models. Scale bars represent 50 μm. b Data of the different kinds of dissectates were compared using a heatmap. All included
genes showed a log2 fold increase equal or above 2 and a p value below 0.05
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performing RNA sequencing on dissected B cell aggre-
gates from chronic MP4-EAE mice, we detected a range
of upregulated molecules compared to SLOs and to the
MOG:35–55 model. In particular, we detected a signifi-
cantly higher expression of Il17f, which is characteristic
of TH17 cells [33]. Moreover, B cell aggregates expressed
two members of the Mmp gene family, i.e., Mmp3 and
Mmp10. On the one hand, MMP-3 has been shown to
assert neuroprotective function, e.g., by reducing Fas/
FasL-mediated apoptosis [34]. On the other hand,
MMP-3 could be involved in the pathophysiology of MS
by degrading the blood brain barrier [35]. Unlike
MMP-3, MMP-10 has not been mentioned in associ-
ation with MS before. Yet, MMP-10 has been described
to play a role in autoimmune processes in synovial path-
ology [36]. Furthermore, HSPs were highly expressed in
MP4-related B cell aggregates. It is a moot question,
whether heat shock proteins of the HSP70 family play a
negative or beneficial role in MS pathogenesis, because
of their contradictory function. Besides a neuroprotec-
tive role, HSP70 acts as an immunomodulator, for ex-
ample by triggering the expression of pro-inflammatory
cytokines [37, 38]. Moreover, it has been suggested that
FAM19A2 has an immunomodulatory function, acts as a
neurokine, and might be involved in axonal sprouting
[39]. In addition, RNA sequencing showed further genes
to be upregulated in B cell aggregates of the MP4 model.
Although all of these genes have not been described in
association with neurological diseases and autoimmunity
before and there are currently no reports that they are
involved in the process of ectopic tissue formation, they
should not be excluded from further investigation.
Conclusion
This study focused on the mechanisms and molecules,
which could be involved in ectopic lymphoid tissue
formation in the CNS. LTi cells, the initiators of SLO
development, did not seem to play an important role in
the investigated process. Furthermore, only a small
amount of ILCs was present in the CNS. Corresponding
to a previously postulated role of TH17 cells in B cell ag-
gregate formation, we detected such cells in the CNS of
MP4-immunized mice. In addition, we observed the up-
regulation of specific genes in association with B cell ag-
gregates in the cerebellum of MP4-immunized mice.
Whether and how each of these genes and their prod-
ucts are involved in the development of ectopic lymph-
oid organs remains to be shown.
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